Latest 30 funded companies from our investment coverage. Search all 1750 startup profiles, or open an industry hub.

Latest funded startups

The newest 30 financed companies in our coverage. Search the full set of 1750 profiles, or jump to an industry hub — we do not paginate this list into a crawlable dump.

Company Latest round Industries
Valon

Independent mortgage-servicing software company behind ValonOS; sold its Valon Mortgage servicing subsidiary to Carrington in August 2026.

Seed —
OpenAI

Frontier AI lab behind ChatGPT, GPT models, and API platform for developers and enterprises.

growth —
North.cloud

Cloud, AI and data-spend intelligence and automated financial-operations platform.

2026-10-15 · Series B · Company-announced financing; exact legal completion date not separately specified. Announcement date used. —
Opsin

AI-agent security platform connecting identity, access, purpose and observed activity.

2026-10-15 · Company-disclosed financing; formal stage and cumulative reconciliation unspecified · $21M disclosed October 15. Formal stage, instrument breakdown and reconciliation with 2025 $7M seed not disclosed; do not infer $28M total. —
Abby Care

Clinically supported family-caregiving provider combining caregiver training, pay and care documentation.

2026-10-15 · Series C · Company confirms close and syndicate; $82M and Series C designation from Home Health Care News, citing Fortune. —
Mueon

Developing modular 3D compute-and-memory systems for AI and hyperscale infrastructure.

2026-10-15 · Series A · Company-announced financing; exact legal completion date not separately specified. Announcement date used. —
OMass Therapeutics

Oxford biotech developing small-molecule medicines in endocrinology and immunology.

2026-10-15 · Series C · $310M (£230M) announced Series C; valuation undisclosed. —
Scimplify

Specialty-chemical and advanced-materials process development and manufacturing platform.

2026-10-14 · Strategic equity; formal series undisclosed · $25M new strategic equity, not the $80M cumulative equity total. Reports also identify an unnamed Japanese chemical investor. —
Labelbox

Reinforcement-learning environments, evaluations and managed enterprise agents.

2026-10-14 · Series E equity plus credit facility; split undisclosed · More than $100M combined equity and credit, not pure venture equity or proof all facility funds were drawn. Exact split and credit terms undisclosed. —
Skeleton Technologies

High-power energy-storage systems for AI infrastructure and industrial applications.

2026-10-14 · Strategic investment; formal series undisclosed —
Forgepoint

AI inside-sales software that prepares manufacturing quotes and coordinates approvals.

2026-10-14 · Seed · Company-announced amount; date records announcement, not independently verified bank settlement. —
Altay Therapeutics

Develops oral small-molecule transcription-factor inhibitors, led by DX5057 for FSHD.

2026-10-14 · Series A · Company-announced amount; date records announcement, not independently verified bank settlement. —
SUNMMIO

China-based 3D TokenPU processors for AI inference.

2026-10-14 · Series A —
Tamr

AI-native master-data-management platform for trusted enterprise records.

2026-10-14 · Growth equity —
Confido Health

Healthcare operations platform built from coordinated AI agents.

2026-10-14 · Series A extension —
Harmonic Security

Workforce AI-security platform that controls how employees and agents use generative-AI tools.

2026-10-14 · Series B —
Bedrock Robotics

Retrofit autonomy kit turning 20–80 ton excavators into supervised self-driving earthmovers on construction sites.

2026-10-14 · Reported Series C · Reported as being raised; not company-confirmed or announced closed. —
Modal Labs

NYC serverless cloud for AI workloads — GPUs, sandboxes, batch jobs, and inference without managing clusters.

2026-10-14 · Series D —
Duvo

AI execution system for governed enterprise operations across disconnected software.

2026-10-14 · Series A —
Salience Labs

Silicon-photonic all-optical switches for AI data-center networking.

2026-10-14 · Series B · Confirmed closed. Original eventKey retained to avoid duplicate financing records. —
Astribot

Builds cable-driven AI robots with a proprietary model and embodied operating system.

2026-10-13 · Undisclosed · RMB1 billion completed financing disclosed October 13. Economic Observer reports September completion; exact September close date unknown. —
AGIBOT

Develops general-purpose embodied-AI robots and associated platforms.

2026-10-13 · Reported prospective financing; not closed · Unconfirmed proposed fundraising range; NOT a completed financing. Keep outside confirmed-funding aggregates. —
Readily

Healthcare compliance intelligence linking regulatory changes to accountable actions and evidence.

2026-10-13 · Series A · Company-announced amount; date records announcement, not independently verified bank settlement. —
Reach Security

AI-assisted validation and optimization of enterprises' existing security controls.

2026-10-13 · Series B · Strictly more than $50 million; numeric minimum is a disclosed lower bound, not an exact amount. —
Pluto Security

Security controls for the software employees build and run with AI.

2026-10-13 · Seed — historical financing disclosure · Approximately $8.5M prior seed; original close date not disclosed. Event date is public disclosure, not close. —
Soufflé Therapeutics

Receptor-targeted RNA medicines designed to reach tissues beyond the liver.

2026-10-13 · Series B —
Proscia

Digital-pathology workflow and AI software for laboratories and biopharma.

2026-10-13 · Definitive agreement; not closed · $240M cash at closing plus up to $30M in performance payments. —
Switched Source

Power-electronics systems that unlock distribution-grid capacity without rebuilding lines.

2026-10-13 · Stage undisclosed · Company disclosed 'over $17 million'; no exact upper bound or formal stage. —
Causa Prima

AI agents that settle B2B invoices between buyers and suppliers.

2026-10-13 · Seed —
Archa

Australian corporate-card and spend-management platform extending business credit without personal guarantees.

2026-10-13 · Debt facility; provider and terms undisclosed · Debt capital for expanding Archa's customer-credit capacity. Lender, interest rate, maturity and covenants were not disclosed. —